Bank Mandiri (Persero) Tbk PT
OTC:PPERF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bank Mandiri (Persero) Tbk PT
OTC:PPERF
|
ID |
|
R
|
Roche Holding AG
DUS:RHO
|
CH |
|
C
|
Coca-Cola Co
XMUN:CCC3
|
US |
|
C
|
Clinomics Inc
KOSDAQ:352770
|
KR |
|
S
|
Square Enix Holdings Co Ltd
F:EI4
|
JP |
|
H
|
HAL Trust
OTC:HALFF
|
MC |
|
C
|
Courage Investment Group Ltd
SGX:CIN
|
HK |
|
C
|
Crowd Media Holdings Ltd
F:CM3
|
AU |
|
YD Bio Ltd
NASDAQ:YDES
|
TW |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
US |
Wall Street
Price Targets
PPERF Price Targets Summary
Bank Mandiri (Persero) Tbk PT
According to Wall Street analysts, the average 1-year price target for
PPERF
is 0.3771 USD
with a low forecast of 0.2352 USD and a high forecast of 0.5401 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PPERF's stock price target?
Price Target
0.3771
USD
According to Wall Street analysts, the average 1-year price target for
PPERF
is 0.3771 USD
with a low forecast of 0.2352 USD and a high forecast of 0.5401 USD.
What is Bank Mandiri (Persero) Tbk PT's Revenue forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Bank Mandiri (Persero) Tbk PT's revenue is
11%.
The projected
CAGR
for the next 3 years is
9%.
What is Bank Mandiri (Persero) Tbk PT's Net Income forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
Bank Mandiri (Persero) Tbk PT's net income is
12%.
The projected
CAGR
for the next 3 years is
7%.
